01-01-1970 12:00 AM | Source: Reuters
India's Bharat Biotech says regulatory steps taken for Brazil vaccine contract
BENGALURU - India's Bharat Biotech said on Wednesday it followed a "step-by-step" approach for the regulatory approval and supply contract of its COVID-19 vaccine in Brazil, and that it has not received advance payments from the Brazilian health ministry.
Brazil's health minister said on Tuesday the country will suspend its $324 million contract for 20 million doses of Bharat Biotech's vaccine after whistleblowers went public with alleged irregularities in the deal.
(Reporting by Anuron Kumar Mitra in Bengaluru, Editing by Sherry Jacob-Phillips)
Latest News
Hold Grasim Industries Ltd For Target Rs. 2,777 By C...
Buy Bharat Dynamics Ltd For Target Rs. 1445 By Choic...
Sagarmanthan maritime meet kicks off in Delhi on Monday
Indian economy capable of handling global shocks: RB...
India has become a market that you can`t ignore: Glo...
Market Outlook By Dr. Vikas Gupta, CEO and Chief Inv...
Goods traffic doubles on the new railway freight cor...
Tata seals deal with Pegatron for iPhone plant in In...
Tomato prices drop 22.5 pc as flow of fresh crop pic...
India clocks 12 pc rise in deal volume in Jan-Oct, C...
Tag News
Bharat Biotech evinces interest to invest in Karnataka
Key Stock News: JSW Group , Aditya Birla Fashion and Retail Limited , Bharat Biotech , Adani group - ARETE Securities
Key News - Vedanta Ltd, Mindtree Ltd, Reliance Industries Limited Ltd, Bharat Biotech, Braithwaite & Co Ltd By ARETE Securities
DGCI approves for phase III trial of Bharat Biotech intranasal vaccine as booster